Bath & Body Works (XTER:LTD0) Research & Development: €0 Mil (TTM As of Apr. 2026)


XTER:LTD0 Bath & Body Works Inc XTER:LTD0
64 GF Score
Price €17.65
GF Value €27.58
! 4 Warning Signs
View Full Analysis

What is Bath & Body Works Research & Development?

Bath & Body Works XTER:LTD0 +0.75% 64 Research & Development is €0 Mil as of Apr. 2026. GuruFocus rates XTER:LTD0 with a GF Score™ of 64/100 and a GF Value™ of €27.58. The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Bath & Body Works's Research & Development for the three months ended in Apr. 2026 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Apr. 2026 was €0 Mil.

Bath & Body Works  (XTER:LTD0) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Bath & Body Works Research & Development Related Terms

Bath & Body Works Research & Development Historical Data

* Premium members only.

The historical data trend for Bath & Body Works's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bath & Body Works Research & Development Chart

Bath & Body Works Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Bath & Body Works Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XTER:LTD0
64GF Score
Bath & Body Works Inc XTER:LTD0
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bath & Body Works Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0 Mil mean?
Bath & Body Works (XTER:LTD0) has a Research & Development of €0 Mil as of Apr. 2026. Research and development expense is the total cost for research and development activities. View historical data on Bath & Body Works and its competitors.
Is Bath & Body Works' Research & Development too high?
Bath & Body Works' current Research & Development is €0 Mil. Overall, Bath & Body Works has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.
How does Bath & Body Works' Research & Development compare to MNSO and ASO?
Bath & Body Works' Research & Development of €0 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Retail - Cyclical company?
A good Research & Development depends on the Retail - Cyclical industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Bath & Body Works and its competitors. Bath & Body Works's current Research & Development is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bath & Body Works stock overvalued right now?
Bath & Body Works (XTER:LTD0) has a current Research & Development of €0 Mil. The stock's GF Value™ is €27.58, compared to a current price of €17.65 — trading 36% below its estimated fair value. The current Research & Development is €0 Mil. Bath & Body Works' overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Bath & Body Works (XTER:LTD0), the current Research & Development is €0 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bath & Body Works (XTER:LTD0) Overvalued in 2026?

Based on GuruFocus' analysis, Bath & Body Works stock appears to be undervalued. The current stock price of €17.65 is trading 36% below its estimated GF Value™ of €27.58.

Key valuation signals for XTER:LTD0:

  • Research & Development: €0 Mil
  • GF Value™: €27.58 vs. price of €17.65 (36% below fair value)
  • GF Score™: 64/100 with 4 warning signs

No single metric tells the full story. See the XTER:LTD0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bath & Body Works Business Description

Address Three Limited Parkway, Columbus, OH, USA, 43230
Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with just 4% of sales from international markets in fiscal 2025. For fiscal 2025, 77% of sales stemmed from the brick-and-mortar network of more than 1,900 retail stores, similar to 2024 levels, as consumer shopping patterns remained normal. Future growth is expected from store upgrades, digital and international channels, as well as adjacent category expansions like men's and lip.
64GF Score

Get the complete analysis for XTER:LTD0

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€17.65
Price
€27.58
GF Value